financetom
Business
financetom
/
Business
/
Hims & Hers Health Unusual Options Activity For February 10
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hims & Hers Health Unusual Options Activity For February 10
Feb 10, 2025 11:26 AM

Financial giants have made a conspicuous bearish move on Hims & Hers Health ( HIMS ). Our analysis of options history for Hims & Hers Health ( HIMS ) revealed 60 unusual trades.

Delving into the details, we found 23% of traders were bullish, while 56% showed bearish tendencies. Out of all the trades we spotted, 36 were puts, with a value of $2,802,706, and 24 were calls, valued at $1,598,109.

Projected Price Targets

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $17.0 to $55.0 for Hims & Hers Health ( HIMS ) over the recent three months.

Volume & Open Interest Development

Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Hims & Hers Health's ( HIMS ) options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Hims & Hers Health's ( HIMS ) significant trades, within a strike price range of $17.0 to $55.0, over the past month.

Hims & Hers Health Option Activity Analysis: Last 30 Days

Significant Options Trades Detected:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
HIMS PUT SWEEP NEUTRAL 04/17/25 $7.7 $7.5 $7.7 $44.00 $359.2K 5.0K 2.0K
HIMS PUT SWEEP BEARISH 04/17/25 $7.65 $7.45 $7.62 $44.00 $289.3K 5.0K 765
HIMS PUT SWEEP BEARISH 04/17/25 $7.75 $7.5 $7.72 $44.00 $258.4K 5.0K 515
HIMS CALL TRADE BULLISH 03/21/25 $6.9 $6.75 $6.9 $44.00 $207.0K 150 627
HIMS PUT SWEEP BULLISH 04/17/25 $3.95 $3.9 $3.95 $37.00 $201.1K 235 511

About Hims & Hers Health

Hims & Hers Health Inc ( HIMS ) is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.

Present Market Standing of Hims & Hers Health

With a volume of 9,517,823, the price of HIMS is up 3.76% at $44.15.

RSI indicators hint that the underlying stock may be overbought.

Next earnings are expected to be released in 14 days.

Unusual Options Activity Detected: Smart Money on the Move

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Hims & Hers Health ( HIMS ) with Benzinga Pro for real-time alerts.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Byrna Technologies Names Lauri Kearnes CFO
Byrna Technologies Names Lauri Kearnes CFO
Jun 24, 2024
08:32 AM EDT, 06/24/2024 (MT Newswires) -- Byrna Technologies ( BYRN ) said Monday it has named Lauri Kearnes as chief financial officer, effective July 15. The company said Kearnes, who will succeed retiring CFO David North, was most recently the finance chief at Harte Hanks ( HHS ) . Shares of Byrna ( BYRN ) were 1.4% higher in...
Alithya Group CFO to Depart; Interim Replacement Named
Alithya Group CFO to Depart; Interim Replacement Named
Jun 24, 2024
08:36 AM EDT, 06/24/2024 (MT Newswires) -- Alithya Group ( ALYAF ) said Monday that Claude Thibault is stepping down as chief financial officer of the company to pursue other endeavours. The company has tapped Debbie Di Gregorio to serve as interim chief financial officer, effective June 28. Di Gregorio joined Alithya ( ALYAF ) in October 2018 as vice...
GSK Says Omjjara Approved in Japan to Treat Myelofibrosis
GSK Says Omjjara Approved in Japan to Treat Myelofibrosis
Jun 24, 2024
08:32 AM EDT, 06/24/2024 (MT Newswires) -- GSK (GSK) said in a regulatory filing Monday that Japan's Ministry of Health, Labour and Welfare has approved Omjjara for the treatment of myelofibrosis, a rare blood cancer. The approval was based on data from the Momentum and Simplify-1 pivotal phase 3 trials, GSK said in a 6-K filing with the US Securities...
Agnico Eagle Mines Invests $2.9 Million in Maple Gold Mines
Agnico Eagle Mines Invests $2.9 Million in Maple Gold Mines
Jun 24, 2024
08:32 AM EDT, 06/24/2024 (MT Newswires) -- Agnico Eagle Mines ( AEM ) said on Monday that it bought about 33.8 million Maple Gold Mines ( MGMLF ) common shares on June 21 at $0.085 apiece for about $2.9 million. The sellers had acquired the shares in connection with an offering of flow-through common shares issued by Maple. Agnico Eagle...
Copyright 2023-2026 - www.financetom.com All Rights Reserved